Hainan Honz Pharmaceutical Co Net Asset Quality Index
Hainan Honz Pharmaceutical Co net asset quality index. Hainan Honz Pharmaceutical Co (300086) has a Net Asset Quality Index of 51.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.71 Billion minus total liabilities of CN¥824.00 Million yields net assets of CN¥887.65 Million. A higher index indicates a stronger, lower-leverage balance sheet. See 300086 net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hainan Honz Pharmaceutical Co (2007–2025)
Net asset quality index of Hainan Honz Pharmaceutical Co from 2007 to 2025. This chart shows how Hainan Honz Pharmaceutical Co's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 51.9%, representing net assets of CN¥887.65 Million against total assets of CN¥1.71 Billion CNY. Check 300086 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Hainan Honz Pharmaceutical Co Net Asset Quality Index by Year (2007–2025)
Hainan Honz Pharmaceutical Co net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hainan Honz Pharmaceutical Co from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300086 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.4% | CN¥921.22 Million | CN¥1.79 Billion | CN¥869.79 Million | ▼ -7.5 pp |
| 2024 | 59.0% | CN¥1.17 Billion | CN¥1.98 Billion | CN¥810.53 Million | ▼ -4.7 pp |
| 2023 | 63.6% | CN¥1.38 Billion | CN¥2.17 Billion | CN¥787.60 Million | ▲ +4.4 pp |
| 2022 | 59.2% | CN¥1.36 Billion | CN¥2.29 Billion | CN¥932.96 Million | ▼ -4.0 pp |
| 2021 | 63.2% | CN¥1.55 Billion | CN¥2.46 Billion | CN¥905.14 Million | ▲ +1.9 pp |
| 2020 | 61.3% | CN¥1.60 Billion | CN¥2.61 Billion | CN¥1.01 Billion | ▼ -11.7 pp |
| 2019 | 73.0% | CN¥1.60 Billion | CN¥2.19 Billion | CN¥592.59 Million | ▼ -2.8 pp |
| 2018 | 75.8% | CN¥1.65 Billion | CN¥2.18 Billion | CN¥526.90 Million | ▼ -10.1 pp |
| 2017 | 85.9% | CN¥1.92 Billion | CN¥2.24 Billion | CN¥315.31 Million | ▲ +0.4 pp |
| 2016 | 85.5% | CN¥1.87 Billion | CN¥2.19 Billion | CN¥316.83 Million | ▼ -2.6 pp |
| 2015 | 88.1% | CN¥1.84 Billion | CN¥2.09 Billion | CN¥248.25 Million | ▼ -5.5 pp |
| 2014 | 93.6% | CN¥1.80 Billion | CN¥1.93 Billion | CN¥122.49 Million | ▼ -1.4 pp |
| 2013 | 95.0% | CN¥1.81 Billion | CN¥1.90 Billion | CN¥94.36 Million | ▼ -0.1 pp |
| 2012 | 95.2% | CN¥1.87 Billion | CN¥1.97 Billion | CN¥95.02 Million | ▲ +0.8 pp |
| 2011 | 94.4% | CN¥1.85 Billion | CN¥1.96 Billion | CN¥110.77 Million | ▼ -1.6 pp |
| 2010 | 96.0% | CN¥1.83 Billion | CN¥1.90 Billion | CN¥76.01 Million | ▲ +14.2 pp |
| 2009 | 81.8% | CN¥240.49 Million | CN¥294.09 Million | CN¥53.60 Million | ▲ +8.9 pp |
| 2008 | 72.9% | CN¥150.41 Million | CN¥206.34 Million | CN¥55.93 Million | ▼ -9.0 pp |
| 2007 | 81.9% | CN¥115.89 Million | CN¥141.57 Million | CN¥25.68 Million | — |